Duodenal-jejunal bypass liner therapy (Endobarrier®) causes reductions in plasma trimethylamine-N-oxide in obese patients with diabetes

A Ruban; M Glaysher; H Ashrafian; A Miras; C Prechtl; A Goldstone; M Aldhwayan; N Chhina; W Al-Najim; J Li; J Byrne; J Teare

doi:10.1136/gutjnl-2020-bsgcampus.33

Duodenal-jejunal bypass liner therapy (Endobarrier®) causes reductions in plasma trimethylamine-N-oxide in obese patients with diabetes

A Ruban, M Glaysher, H Ashrafian, A Miras, C Prechtl, A Goldstone, M Aldhwayan, N Chhina, W Al-Najim, J Li, J Byrne, J Teare

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

Original language	English
Title of host publication	GUT
Publisher	BMJ Publishing Group
Pages	A19-A19
Volume	70
Edition	Issue Suppl 1
DOIs	https://doi.org/10.1136/gutjnl-2020-bsgcampus.33
Publication status	Published online - 21 Jan 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/gutjnl-2020-bsgcampus.33

Cite this

Ruban, A., Glaysher, M., Ashrafian, H., Miras, A., Prechtl, C., Goldstone, A., Aldhwayan, M., Chhina, N., Al-Najim, W., Li, J., Byrne, J., & Teare, J. (2021). Duodenal-jejunal bypass liner therapy (Endobarrier®) causes reductions in plasma trimethylamine-N-oxide in obese patients with diabetes. In GUT (Issue Suppl 1 ed., Vol. 70, pp. A19-A19). BMJ Publishing Group. Advance online publication. https://doi.org/10.1136/gutjnl-2020-bsgcampus.33

@inproceedings{3e4ba1853bf14f64b87381923199bb05,

title = "Duodenal-jejunal bypass liner therapy (Endobarrier{\textregistered}) causes reductions in plasma trimethylamine-N-oxide in obese patients with diabetes",

author = "A Ruban and M Glaysher and H Ashrafian and A Miras and C Prechtl and A Goldstone and M Aldhwayan and N Chhina and W Al-Najim and J Li and J Byrne and J Teare",

year = "2021",

month = jan,

day = "21",

doi = "10.1136/gutjnl-2020-bsgcampus.33",

language = "English",

volume = "70",

pages = "A19--A19",

booktitle = "GUT",

publisher = "BMJ Publishing Group",

address = "United Kingdom",

edition = "Issue Suppl 1",

}

Ruban, A, Glaysher, M, Ashrafian, H, Miras, A, Prechtl, C, Goldstone, A, Aldhwayan, M, Chhina, N, Al-Najim, W, Li, J, Byrne, J & Teare, J 2021, Duodenal-jejunal bypass liner therapy (Endobarrier®) causes reductions in plasma trimethylamine-N-oxide in obese patients with diabetes. in GUT. Issue Suppl 1 edn, vol. 70, BMJ Publishing Group, pp. A19-A19. https://doi.org/10.1136/gutjnl-2020-bsgcampus.33

TY - GEN

T1 - Duodenal-jejunal bypass liner therapy (Endobarrier®) causes reductions in plasma trimethylamine-N-oxide in obese patients with diabetes

AU - Ruban, A

AU - Glaysher, M

AU - Ashrafian, H

AU - Miras, A

AU - Prechtl, C

AU - Goldstone, A

AU - Aldhwayan, M

AU - Chhina, N

AU - Al-Najim, W

AU - Li, J

AU - Byrne, J

AU - Teare, J

PY - 2021/1/21

Y1 - 2021/1/21

U2 - 10.1136/gutjnl-2020-bsgcampus.33

DO - 10.1136/gutjnl-2020-bsgcampus.33

M3 - Conference contribution

VL - 70

SP - A19-A19

BT - GUT

PB - BMJ Publishing Group

ER -